Amniotic Membrane Market: Significance & Global Performance

1
Amniotic Membrane Market Significance Global
Performance
Amniotic membrane or amnion, a thin membrane on
the inner side of the fetal placenta and composed
of the epithelium, has emerged as an ideal source
for tissue transplantation. Moreover, amnion has
an array of biological properties, making it
attractive for use in various surgical
procedures, including ocular surface
reconstruction and tissue engineering. The
advancements in anatomy have triggered
significant investments in research and
development of amniotic membrane applications.
While AM has shown beneficial results in burn
injuries, the upsurge in RD investments has
increased its use in eye surgery, cell therapy,
stem cell research, and more, boosting the
amniotic membrane markets growth prospects. In
fact, the identification of new stem cells has
increased the membranes potential, making it
ideal for developing regenerative medicines. For
instance, Organogenesis Holdings Inc, a leading
regenerative medicine company, gained approval
from the US FDA for ReNu, a cryopreserved
amniotic suspension allograft, to manage symptoms
related to knee osteoarthritis.
Amniotic Membrane Market - Global Regional
Trends As per estimates, the global amniotic
membrane market will display revenue growth at a
CAGR of 7.01 during the forecast period
2022-2028. Considering the evolving healthcare
sector, the amniotic membrane market is expected
to witness tremendous growth in the Asia-Pacific
nations. Estimates suggest that approximately
half a billion people in the region will be 65 or
older by 2025. This change in demographics, in
addition to a shift in consumer expectations,
will widen the markets scope. In this regard,
the growing demand for chronic care management
will expand amnion application in ophthalmology,
burn injuries, and cosmetic surgeries, among
others.
2

• Additionally, amniotic membrane transplantation
  has gained momentum in various conjunctival and
  corneal diseases, signaling opportunistic growth
  for players in the APAC region. Considering its
  growth in North America, amnions have proven
  advantageous in treating limbal stem cell
  deficiency, providing support and protection to
  transplanted limbal tissues and stem cells.
  Recently, in Canada, numerous techniques have
  been developed to dehydrate amnion while
  preserving the wound- healing properties to
  formulate a temperature-stable allograft.
• Furthermore, the United Kingdom is the center of
  research and development of amniotic membrane
  applications in Europe. Several hospitals, such
  as NuVision, have gained expertise in providing
  AM treatments. Amniotic membrane treatments are
  gaining center stage across the nation, given the
  technological advancements. For instance, in
  November 2021, several ophthalmologists shared
  their innovations of AM application in treating
  ocular surface conditions through a webinar
  sponsored by NuVision Biotherapies Ltd.
• Market by Application Expert Outlook
• Surgical Wounds Human amniotic membrane has been
  used for treating acute and chronic wounds,
  decreasing infection and pain while accelerating
  the healing time. The surgical wound segment
  dominates the overall market and is expected to
  maintain its stronghold till 2028. Although a
  plethora of wound dressings are available,
  chronic wounds remain a major medical concern. As
  a result, chronic wounds awareness programs
  largely support amnion application. For instance,
  the Wound Healing and Hyperbaric Center at
  Carteret Health Care, a Healogic Network member,
  is engaged in raising awareness of chronic
  wounds, providing advanced therapies.
• Ophthalmology The rise in chronic and infectious
  diseases has resulted in a global rise in
  surgeries, boosting the markets potential.
  Amniotic membrane is rapidly used in ophthalmic
  surgeries to initiate faster recovery and
  decrease inflammation. Amnion has become crucial
  in eye treatments, given its anti-scarring and
  anti-inflammatory properties. For instance, Bio
  Tissue Inc offers AmnioGraft to treat ocular
  surface indications like corneal ulcers, dry eye,
  chemical burns, etc. Besides, AM is highly
  preferred in developing regions since it is
  cheaper than allografts.
• Competitive Analysis
• For any company, acquisitions and agreements
  ensure expansion in business footings.
  Acquisitions, for instance, are quicker, cheaper,
  and less risky compared to other methods to
  extend volume sales. On the other hand,
  agreements are crucial to eliminating
  disagreements, confusion, or changes that may
  transpire during the course of the business
  period.
• Notable acquisitions and agreements that support
  the markets development
• In February 2021, Katena Products Inc, a leading
  provider of premium ophthalmic instruments and
  devices, announced the acquisition of ASICO LLC
  to expand the ophthalmic surgical product line
  and lead in the innovation of new products.
• Integra LifeSciences Corporation, in January
  2021, acquired ACell Inc and its proprietary
• MatriStem UMB to offer comprehensive wound
  management solutions.

3

• Celularity Inc and Oncternal Therapeutics Inc
  entered into a research partnership in September
  2021 to examine placental-derived cellular
  treatments.
• Celularity also collaborated with Imugene Ltd in
  August 2021 to employ Imugenes CD19 oncolytic
  virus technology and its CD19 CYCART-19 to remedy
  solid tumors.
• In Conclusion,
• The amniotic membrane market has shown rapid and
  promising results in healing damaged tissues.
  From chemical burns to ulcers to the cornea,
  amnions have emerged as suitable membranes in
  wound care management. This indicates that the
  use of AM in medicine and therapies is expanding
  in various branches of medicine.

• FAQs Frequently Asked Questions
• How big is the amniotic membrane market?
• As per Triton Market Research, the global
  amniotic membrane will attain revenue worth
  2220.96 million by 2028.
• Which are the key players in the amniotic
  membrane market?
• The key players in the amniotic membrane market
  comprise Sky Biologics LLC, Integra Lifescience
  Corp, Surgenix LLC, Smith and Nephew Plc, Bio
  Tissue Inc, Organogenesis, Human Regenerative
  Technologies, Labtician Ophthalmics Inc, Amniox
  Medical Inc, Katena Products Inc, Amino
  Technology LLC, Surgilogix LLC, MiMedx, and
  Celularity Inc.
• What is the impact of COVID-19 on the amniotic
  membrane Market?
• Check out our summary or get a sample preview of
  the segment https//www.tritonmarketresearch.com/r
  eports/amniotic-membrane-marketrequest-free-sampl
  e